Guardant Health (GH) Sell-Off Makes Neogenomics (NEO) Deal Less Likely - Needham & Company
Go back to Guardant Health (GH) Sell-Off Makes Neogenomics (NEO) Deal Less Likely - Needham & Company| Textainer Group Holdings limited (NASDAQ: GH) | Delayed: 17.70 +0.36 (2.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $17.34 | 52 Week High | $5.84 | |||
| Open | $17.72 | 52 Week Low | $5.49 | |||
| Day High | $17.73 | P/E | N/A | |||
| Day Low | $17.34 | EPS | $0.00 | |||
| Volume | 59,630 | |||||
| NEOGENOMICS (NASDAQ: NEO) | Delayed: 14.06 -0.1 (0.71%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $14.16 | 52 Week High | $9.54 | |||
| Open | $14.12 | 52 Week Low | $5.49 | |||
| Day High | $14.29 | P/E | 351.50 | |||
| Day Low | $14.06 | EPS | $0.04 | |||
| Volume | 17,305 | |||||
